App-Quantinova.ai

Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer

C. Englisch - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Aortic Thrombosis Presenting as Myocardial Infarction in a Child

K. Nelson McMillan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Apixaban for venous thromboembolism treatment in obese patients with weight >120kg or BMI >40 kg m2

T. Groves - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

apixaban

Arterial and venous thrombosis induced by vaccination with ChAdOx1 nCov-19 (Astrazeneca) against Coronavirus 19 (COVID19)

A. VILASECA - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Arterial Thromboembolism Risk Assessment Model in Hospitalized COVID-19 Patients

P. Li - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Artificial Intelligence in the Prediction of Venous Thromboembolism: A Systematic Review and Pooled Analysis

T. Chiasakul - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Assessing research collaboration networks and social media use among venous thromboembolism researchers during the COVID-19 pandemic

D. Karsanji - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Assessment of COVID -19 associated coagulopathy and multiple hemostatic markers in patients of upper Egypt.

A. Abdelaal - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hemostatic Solution

Assessment Of Venous Thromboembolism Risk Factors In Hospitalized Patients At The University of Nigeria Teaching Hospital, Enugu Nigeria

E. EZIGBO - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Association between RET and BRAF(V600) oncogenic status and risk of venous and pulmonary thromboembolism in patients with papillary thyroid cancer

D. Katalinic - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Association of Genetic Variability in MRVI1Gene in Patients With Arterial Thrombosis and Platelet Hyperaggregability

M. Brunclikova - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Association of inflammation and coagulation biomarkers with Cerebral Venous Thrombosis Clinical and Imaging characteristics: results from FPCCVT

P. Billoir - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Association of polygenic risk scores for severe mental illness with risk of venous thromboembolism

R. Strawbridge - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

ATHNdataset Hereditary Antithrombin Deficiency (HAD) Pilot Project (ATHN 12) Registry from the American Thrombosis and Hemostasis Network (ATHN)

M. DeSancho - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Attenuation of Thrombotic Biomarkers in a Hyperlipidaemic Sprague Dawley Rats Model

I. KWAIFA - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Simvastatin

Available Risk Scores Modestly Predict Hemorrhage in Patients with Cancer-Associated Thrombosis (CAT)

K. Sanfilippo - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Benefits of prolonged anticoagulant treatment in a series of cerebral venous thrombosis in pediatric patients

R. Berrueco - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Biomarkers in COVID-19: Association with disease severity and outcomes

M. Peralta - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Bleeding in Patients with Genitourinary Cancer compared to Non-Genitourinary Cancer Treated with Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism

T. Lang - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

Bleeding Outcomes for Patients on Anticoagulant and Antiplatelet Therapy

J. Schaefer - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

warfarin + ASA

Filters

7277 Abstracts